REVOLUTIONIZING INFLAMMATION ASSESSMENT
KeyIn-1
Novel blood biomarker test to assess inflammation and repair in chronic inflammatory diseases.
Applications:
Embedded Files
Chronic Inflammation Progresses ‘Invisibly’!
Drives disease progression for years before diagnosis.
Disease activity remains hidden even when patients’ symptoms improve.
Healthcare is treating blind: Clinical inflammation is not being measured with biologic precision.
❗Improved inflammation biomarkers are needed for axial spondyloarthritis to assist with early diagnosis, to better predict treatment and outcomes
Mathew Brown, Nature Reviews, Rheumatology 2020 16 449
KeyIntel Medical is building the inflammation intelligence layer for chronic disease by introducing KeyIn-1 to the biomarker landscape—making inflammation and repair measurable, actionable, and trackable from a simple blood test, and enabling precision and personalized care in diseases where today’s biomarkers fall short.
Page updated
Google Sites
Report abuse